Rigel to Participate in Upcoming September Investor Conferences
Rigel Pharmaceuticals (NASDAQ:RIGL), a biotechnology company focused on hematologic disorders and cancer, has announced its participation in four major investor conferences this September 2025.
The company's leadership, including CEO Raul Rodriguez and CFO Dean Schorno, will attend the Citi's Biopharma Back to School Conference, Cantor Global Healthcare Conference, Wells Fargo Healthcare Conference, and H.C. Wainwright Global Investment Conference. Company presentations are scheduled at Cantor (September 3, 8:35 a.m. ET) and H.C. Wainwright (September 9, 1:30 p.m. ET), with webcasts available through Rigel's investor relations website.
Rigel Pharmaceuticals (NASDAQ:RIGL), una società biotecnologica specializzata in disturbi ematologici e oncologia, ha annunciato la propria partecipazione a quattro importanti conferenze per investitori previste per settembre 2025.
La direzione dell'azienda, tra cui l'amministratore delegato Raul Rodriguez e il direttore finanziario Dean Schorno, prenderà parte al Citi's Biopharma Back to School Conference, al Cantor Global Healthcare Conference, al Wells Fargo Healthcare Conference e all'H.C. Wainwright Global Investment Conference. Le presentazioni aziendali sono programmate al Cantor (3 settembre, 8:35 a.m. ET) e all'H.C. Wainwright (9 settembre, 1:30 p.m. ET), con webcast disponibili sul sito degli investitori di Rigel.
Rigel Pharmaceuticals (NASDAQ:RIGL), una compañía biotecnológica centrada en trastornos hematológicos y cáncer, ha anunciado su participación en cuatro importantes conferencias para inversores en septiembre de 2025.
La dirección de la empresa, incluidos el CEO Raul Rodriguez y el CFO Dean Schorno, asistirá al Citi's Biopharma Back to School Conference, al Cantor Global Healthcare Conference, al Wells Fargo Healthcare Conference y al H.C. Wainwright Global Investment Conference. Las presentaciones de la compañía están programadas en Cantor (3 de septiembre, 8:35 a.m. ET) y en H.C. Wainwright (9 de septiembre, 1:30 p.m. ET), y habrá retransmisiones web disponibles en el sitio de relaciones con inversores de Rigel.
Rigel Pharmaceuticals (NASDAQ:RIGL)는 혈액 질환 및 암을 전문으로 하는 바이오테크 기업으로, 2025년 9월에 열리는 네 건의 주요 투자자 컨퍼런스에 참가한다고 발표했습니다.
CEO Raul Rodriguez와 CFO Dean Schorno를 포함한 경영진이 Citi's Biopharma Back to School Conference, Cantor Global Healthcare Conference, Wells Fargo Healthcare Conference, H.C. Wainwright Global Investment Conference에 참석합니다. 회사 발표는 Cantor에서(9월 3일, 오전 8:35 ET)과 H.C. Wainwright에서(9월 9일, 오후 1:30 ET)에 예정되어 있으며, Rigel 투자자 관계 웹사이트를 통해 웹캐스트로 시청할 수 있습니다.
Rigel Pharmaceuticals (NASDAQ:RIGL), une société de biotechnologie spécialisée dans les troubles hématologiques et le cancer, a annoncé sa participation à quatre grandes conférences pour investisseurs en septembre 2025.
La direction de l'entreprise, y compris le PDG Raul Rodriguez et le directeur financier Dean Schorno, assistera au Citi's Biopharma Back to School Conference, au Cantor Global Healthcare Conference, au Wells Fargo Healthcare Conference et au H.C. Wainwright Global Investment Conference. Les présentations de la société sont programmées chez Cantor (3 septembre, 8:35 a.m. ET) et chez H.C. Wainwright (9 septembre, 1:30 p.m. ET), avec des webcasts disponibles via le site des relations investisseurs de Rigel.
Rigel Pharmaceuticals (NASDAQ:RIGL), ein Biotechnologieunternehmen mit Schwerpunkt auf hämatologischen Erkrankungen und Krebs, hat seine Teilnahme an vier wichtigen Investorenkonferenzen im September 2025 angekündigt.
Die Unternehmensführung, darunter CEO Raul Rodriguez und CFO Dean Schorno, wird an der Citi's Biopharma Back to School Conference, der Cantor Global Healthcare Conference, der Wells Fargo Healthcare Conference und der H.C. Wainwright Global Investment Conference teilnehmen. Unternehmenspräsentationen sind bei Cantor (3. September, 8:35 a.m. ET) und H.C. Wainwright (9. September, 1:30 p.m. ET) geplant; Webcasts werden über die Investor-Relations-Website von Rigel verfügbar sein.
- None.
- None.
- Citi's 2025 Biopharma Back to School Conference in
Boston, MA
Rigel will participate in one-on-one meetings on Tuesday, September 2. - Cantor Global Healthcare Conference 2025 in
New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Wednesday, September 3, at 8:35 a.m. ET. - 2025 Wells Fargo Healthcare Conference in
Boston, MA
Rigel will participate in one-on-one meetings on Thursday, September 4. - H.C. Wainwright 27th Annual Global Investment Conference in
New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Tuesday, September 9, at 1:30 p.m. ET.
To access the live webcasts or archived recordings of the Cantor and H.C. Wainwright Conference presentations, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
646.461.6387
david.rosen@argotpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-participate-in-upcoming-september-investor-conferences-302538238.html
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
When is Rigel Pharmaceuticals (RIGL) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access Rigel's (RIGL) conference presentations in September 2025?
Which investor conferences is Rigel Pharmaceuticals (RIGL) attending in September 2025?
Who will represent Rigel Pharmaceuticals (RIGL) at the September 2025 investor conferences?
